Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC [Phase 1, Phase 2]
A phase I/II study evaluating a pan-immunotherapy regimen in patients with biliary tract cancer (BTC) is ongoing, with both phase 1 and phas…
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma [Phase 2]
Phase 2 trial investigating gemcitabine, irinotecan, and panitumumab in advanced/metastatic biliary tract adenocarcinoma completed with post…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma [Phase 3]
Phase 3 trial comparing GEMOX to XELOX in advanced biliary tract cancer; status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy [Phase 2]
Phase 2 trial evaluating XELOX in advanced biliary tract carcinoma after failure of gemcitabine-based chemotherapy.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-613 in advanced or metastatic biliary tract cancers, including cholangiocarcinoma and unresectable o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Study of Surufatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma [Phase 2]
Phase 2 trial evaluating surufatinib as second-line therapy in biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating oral rehydration therapy to support short hydration during cisplatin plus gemcitabine chemotherapy in biliary tract…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer [Phase 3]
Phase 3 trial comparing gemcitabine/cisplatin/S-1 versus gemcitabine/cisplatin for biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis [Phase 2]
This document provides an update on a Phase II preoperative chemotherapy trial for biliary tract cancer with node metastasis.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy [Phase 2]
This update reports results from a Phase 2 single-agent trial of regorafenib in patients with advanced or metastatic biliary tract carcinoma…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer [Phase 1]
Phase 1 trial update evaluating BIBW 2992 (afatinib) as add-on to gemcitabine/cisplatin in advanced biliary tract cancer; study terminated w…
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer [Phase 2]
Phase 2 trial update of TH-302 monotherapy as second-line treatment in advanced biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours [Phase 1]
Phase 1 study of varlitinib in Japanese patients with advanced or metastatic solid tumors, including biliary tract cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Preoperative Nutritional Support in Malnutritional Cancer Patients [NA]
A completed clinical trial evaluated preoperative nutritional support in malnourished cancer patients, focusing on pancreatic and biliary ca…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer [Phase 2]
Phase II randomized trial comparing gemcitabine to S-1 as adjuvant therapy after hemihepatectomy for biliary tract cancer; the study has com…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer [Phase 2]
This clinical trial update reports the results of a Phase 2 study evaluating capecitabine, oxaliplatin, and bevacizumab with radiation thera…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients [NA]
The clinical trial evaluating a Ketogen-based Therapeutic Diet for pancreaticobiliary cancer has completed, with Yonsei University as sponso…
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial comparing second-line irinotecan and capecitabine versus irinotecan for biliary tract cancer after gemcitabine and ci…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy [Phase 1]
Completed Phase I study evaluating adjuvant chemotherapy with gemcitabine and cisplatin (GC) in biliary tract cancer patients undergoing sur…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy [Phase 1]
This document reports the completion of a Phase I trial evaluating adjuvant chemotherapy with GS (gemcitabine and S-1) in biliary tract canc…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer [Phase 2]
Phase 2 study evaluating a combination of oxaliplatin, irinotecan, and S-1 in biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers [Phase 2]
This document provides a Phase 2 trial update on apatinib as second-line therapy for advanced refractory biliary tract cancers.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma [Phase 2]
This document reports the completion of a Phase II trial of Refametinib, a MEK inhibitor, as second-line treatment for advanced biliary trac…
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Endoscopic Therapy of Malignant Bile Duct Strictures [NA]
The trial examining endoscopic therapy for malignant bile duct strictures was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer [Phase 2]
A Phase 2 trial evaluating the combination of gemcitabine, oxaliplatin, and bevacizumab in biliary tract cancers (including gallbladder aden…